UWO37 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The UWO37 (HPV16) cell line is derived from the tumor cells of a male patient diagnosed with oral tongue cancer and exhibits expression of Human Papillomavirus type 16 (HPV16). This cell line is pivotal for investigations into the molecular mechanisms by which HPV16 contributes to the pathogenesis of head and neck squamous cell carcinoma (HNSCC). By providing a model system that retains the genetic and phenotypic characteristics of the original tumor, UWO37 enables a detailed exploration of viral oncogenesis, interactions between viral proteins and host cell pathways, and the cellular responses to HPV16 integration. Research utilizing the UWO37 cell line focuses on unraveling the complex interplay between HPV16 and cellular machinery, identifying how viral oncogenes such as E6 and E7 contribute to cell transformation and malignancy. This model is also crucial for screening potential pharmacological agents and for developing gene therapy approaches aimed at targeting specific pathways altered by HPV16. Furthermore, the UWO37 cell line serves as a valuable tool for studying the efficacy and safety of new immunotherapeutic strategies, which could lead to enhanced treatment and prevention of HPV-related cancers. |
|---|---|
| Organism | Human |
| Tissue | Oral cavity; tonsil |
| Disease | Squamous cell carcinoma of the oropharynx |
| Applications | Generating Cisplatin Resistant HPV-positive HNSCC cell lines to study cisplatin resistance in HPV-positive cells |
| Synonyms | University of Western Ontario 37 |
Characteristics
| Age | 64 years |
|---|---|
| Gender | Male |
| Growth properties | Adherent |
Regulatory Data
| Citation | UWO37 (Cytion catalog number 300257) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_B7MH |
Biomolecular Data
| Viruses | Transformant: Human papillomavirus type 16 (HPV16); weak expression of HPV16 E7 |
|---|
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300257-110226 | Certificate of Analysis | 05. Mar. 2026 | 300257 |